Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis Zhengbo SongBaochai LinYiping Zhang Original Paper 13 May 2012 Pages: 1613 - 1617
CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α) Chuanyang SunHui SongLiang Zhang Original Paper 22 May 2012 Pages: 1619 - 1624
Comparison of the efficacy and the toxicity between gemcitabine with capecitabine (GC) and gemcitabine with erlotinib (GE) in unresectable pancreatic cancer Eun Kyoung JeonHye-Sung WonMyung Ah Lee Original Paper 22 May 2012 Pages: 1625 - 1630
Prognostic value of tumor progression-related gene expression in colorectal cancer patients Miriam E. UhlmannMilka GeorgievaMartin R. Berger Original Paper 22 May 2012 Pages: 1631 - 1640
miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes Yong-Kui ZhangWang-Yu ZhuXiao-Guang Liu Original Paper 22 May 2012 Pages: 1641 - 1650
Fusion between tumor cells enhances melanoma metastatic potential Ruifang MiChunxiao PanJianhui Ma Original Paper 24 May 2012 Pages: 1651 - 1658
The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors Bing WangQingyun Zhang Original Paper 26 May 2012 Pages: 1659 - 1666
The identification of significant chromosomal regions correlated with oral tongue cancer progression Ki-Yeol KimIn-Ho Cha Original Paper 26 May 2012 Pages: 1667 - 1677
Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study Murat ZorIbrahim YildirimMurat Dayanc Original Paper 26 May 2012 Pages: 1679 - 1682
Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival Matt WilliamsZi Wei LiuElena Wilson Original Paper 27 May 2012 Pages: 1683 - 1688
XPD Asp312Asn polymorphism is a risk factor for prostate cancer Shao-Guang LiaoLu LiuYa-Jie Wang Original Paper 29 May 2012 Pages: 1689 - 1695
Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma Marta HegyiÁgnes GulácsiGábor T. Kovács Original Paper 01 June 2012 Pages: 1697 - 1702
N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer Xiu-Hong LvJia-Wei ChenGuang-Hui Zhu Original Paper 08 June 2012 Pages: 1703 - 1715
Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma Ying JinXiu-Yu CaiWen-Qi Jiang Original Paper 10 June 2012 Pages: 1717 - 1725
Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production Guangying DuLiang YeJingwei Tian Original Paper 15 June 2012 Pages: 1727 - 1736
Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? Linlin LiuNian LiuJun Wei Original Paper 15 June 2012 Pages: 1737 - 1742
Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB Moon Hee YangKyu Taek LeeJong Chul Rhee Original Paper 15 June 2012 Pages: 1743 - 1751
HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents Emmanuelle TavernierPascale Flandrin-GrestaLydia Campos Original Paper 17 June 2012 Pages: 1753 - 1758
Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer Yaming DuLeizhi ShiZhongbin Wang Original Paper 20 June 2012 Pages: 1759 - 1767
Expression and biological role of δ-catenin in human ovarian cancer Yuanyuan FangZhengtao LiShulan Zhang Original Paper 15 June 2012 Pages: 1769 - 1776
Erratum to: Expression and biological role of δ-catenin in human ovarian cancer Yuanyuan FangZhengtao LiShulan Zhang Erratum 06 September 2012 Pages: 1777 - 1777
RETRACTED ARTICLE: Radioembolization using Yttrium-90 microspheres in 58 patients with liver metastases from breast cancer Changming ShenXueling YangQiang Li Original Paper 22 June 2012 Pages: 1779 - 1779
miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer Zhiwei ZhongZhuo DongZhaohui Gong Rapid Communication 18 July 2012 Pages: 1781 - 1788
